Pila Pharma AB (publ) (STO:PILA)

Pila Pharma AB Statistics

Total Valuation

Pila Pharma AB has a market cap or net worth of SEK 55.89 million. The enterprise value is 39.99 million.

Market Cap	55.89M
Enterprise Value	39.99M

Important Dates

The last earnings date was Tuesday, February 10, 2026.

Earnings Date	Feb 10, 2026
Ex-Dividend Date	n/a

Share Statistics

Pila Pharma AB has 42.08 million shares outstanding. The number of shares has increased by 35.92% in one year.

Current Share Class	42.08M
Shares Outstanding	42.08M
Shares Change (YoY)	+35.92%
Shares Change (QoQ)	+55.14%
Owned by Insiders (%)	13.57%
Owned by Institutions (%)	7.05%
Float	31.37M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	49.59
PB Ratio	3.78
P/TBV Ratio	3.78
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-2.37
EV / Sales	35.48
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 11.26

Current Ratio	11.26
Quick Ratio	11.19
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-36.05

Financial Efficiency

Return on equity (ROE) is -168.25% and return on invested capital (ROIC) is -49.23%.

Return on Equity (ROE)	-168.25%
Return on Assets (ROA)	-43.97%
Return on Invested Capital (ROIC)	-49.23%
Return on Capital Employed (ROCE)	-53.40%
Weighted Average Cost of Capital (WACC)	5.54%
Revenue Per Employee	1.13M
Profits Per Employee	-16.86M
Employee Count	1
Asset Turnover	0.10
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -70.73% in the last 52 weeks. The beta is 0.23, so Pila Pharma AB's price volatility has been lower than the market average.

Beta (5Y)	0.23
52-Week Price Change	-70.73%
50-Day Moving Average	1.94
200-Day Moving Average	2.50
Relative Strength Index (RSI)	33.80
Average Volume (20 Days)	550,049

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Pila Pharma AB had revenue of SEK 1.13 million and -16.86 million in losses. Loss per share was -0.62.

Revenue	1.13M
Gross Profit	-5.82M
Operating Income	-7.89M
Pretax Income	-16.86M
Net Income	-16.86M
EBITDA	-6.82M
EBIT	-7.89M
Loss Per Share	-0.62

Balance Sheet

The company has 15.90 million in cash and n/a in debt, with a net cash position of 15.90 million or 0.38 per share.

Cash & Cash Equivalents	15.90M
Total Debt	n/a
Net Cash	15.90M
Net Cash Per Share	0.38
Equity (Book Value)	14.78M
Book Value Per Share	0.35
Working Capital	14.72M

Cash Flow

Operating Cash Flow	-9.19M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross Margin	n/a
Operating Margin	-700.44%
Pretax Margin	-1,496.27%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Pila Pharma AB does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-35.92%
Shareholder Yield	-35.92%
Earnings Yield	-30.17%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Pila Pharma AB has an Altman Z-Score of 30.42 and a Piotroski F-Score of 3.

Altman Z-Score	30.42
Piotroski F-Score	3